Rui Wang

Rui Wang

Auto-generated profile, based on publicly available information

Rui Wang

Zhejiang Key Laboratory of Particle Radiotherapy Equipment , Hangzhou , Zhejiang , China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2020 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
JLJian Liu
Jian Liu
Kai LiKai Li
Kai Li
RWRui Wang
Rui Wang
SCSisi Chen
Sisi Chen
JWJie Wu
Jie Wu
YPYamei Pang
Yamei Pang
Background: Activating transcription factor 2 (ATF2), a member of the activator protein 1 (AP-1) transcription factor family, has been shown to be involved in the pathobiology of numerous cancers. However, the biological role and mechanism of ATF2 in lung adenocarcinoma (LUAD) remains to be elucidated. Methods: The expression of ATF2, NEAT1 and miR-26a-5p in LUAD tissues and cell lines was detected by qRT-PCR and western blotting. The interaction between ATF2, NEAT1, and miR-26a-5p was validated by chromatin immunoprecipitation, luciferase reporter assay and RNA immunoprecipitation. Cell proliferation, invasion and tumorigenesis of LUAD cells were analyzed by using CCK8, transwell invasion assay and xenograft tumor model. Results: We confirmed that ATF2 expression was increased in LUAD tissues compared with normal adjacent lung tissues. Functional experiments showed that ATF2 positively regulated cell proliferation and invasion in LUAD cells. Moreover, we identified that NEAT1 expression was increased in LUAD tissues and positively correlated with ATF2 expression. Mechanistically, ATF2 could bind to the promoter of NEAT1 to promote its transcription. Rescue experiments showed that ATF2 exerted its oncogenic function in LUAD, at least, partly through NEAT1 upregulation. In turn, NEAT1 could positively regulate ATF2 expression and form a positive feedback loop in LUAD cells. Furthermore, we demonstrated that NEAT1 positively regulated ATF2 expression via sponging miR-26a-5p. Conclusion: ATF2 and NEAT1 form a positive feedback loop mediated by miR-26a-5p and coordinately contribute to LUAD progression.

6 February 2016 in Cell Adhesion & Migration
Verified
Journal Article
Open access
LCLina Cui
Lina Cui
HWHuiying Wang
Huiying Wang
XLXiaoyin Lu
Xiaoyin Lu
RWRui Wang
Rui Wang
RZRu Zheng
Ru Zheng
Hongmei WangHongmei Wang
Hongmei Wang
The placental syncytiotrophoblast, which is formed by the fusion of cytotrophoblast cells, is indispensable for the establishment and maintenance of normal pregnancy. The human endogenous retrovirus envelope glycoprotein syncytin-2 is the most important player in mediating trophoblast cell-cell fusion as a fusogen. We constructed expression plasmids of wild-type and 21 single-amino-acid substitution mutants of syncytin-2, including 10 N-glycosylation sites individually silenced by mutagenizing N to Q, 1 naturally occurring single-nucleotide polymorphism (SNP) N118S that introduced an N-glycosylation site, and another 10 non-synonymous SNPs located within important functional domains. We observed that syncytin-2 was highly fusogenic and that the mutants had different capacities in merging 293T cells. Of the 21 mutants, N133Q, N312Q, N443Q, C46R (in the CXXC motif) and R417H (in the heptad repeat region and immunosuppressive domain) lost their fusogenicity, whereas N332Q, N118S, T367M (in the fusion peptide), V483I (in the transmembrane domain) and T522M (in the cytoplasmic domain) enhanced the fusogenic activity. We also proved that N133, N146, N177, N220, N241, N247, N312, N332 and N443 were all glycosylated in 293T cells. A co-immunoprecipitation assay showed compromised interaction between mutants N443Q, C46R, T367M, R417H and the receptor MFSD2A, whereas N118S was associated with more receptors. We also sequenced the coding sequence of syncytin-2 in 125 severe pre-eclamptic patients and 272 normal pregnant Chinese women. Surprisingly, only 1 non-synonymous SNP T522M was found and the frequencies of heterozygous carriers were not significantly different. Taken together, our results suggest that N-glycans at residues 133, 312, 332 and 443 of syncytin-2 are required for optimal fusion induction, and that SNPs C46R, N118S, T367M, R417H, V483I and T522M can alter the fusogenic function of syncytin-2.

1 January 2026 in Human Mutation
Verified
Journal Article
Open access
PDF file
FXFu Xinmo
Fu Xinmo
BMBai Minghua
Bai Minghua
QXQiu Xu
Qiu Xu
LWLi Weiwei
Li Weiwei
WLWang Lin
Wang Lin
JZJi Zhu
Ji Zhu
Background: Radiotherapy resistance limits colorectal cancer (CRC) treatment efficacy, with only 15%–20% of patients achieving a complete response. Validated biomarkers predicting treatment response and serving as therapeutic targets are critically needed. Methods: We performed integrative multiomics analysis of 200 CRC patients (GSE87211) with independent validation in 58 patients (GSE46862). Single‐cell RNA sequencing of 63,689 cells (GSE132465) determined cell‐type‐specific expression. Functional validation was conducted in radiotherapy‐resistant CRC cell lines through loss‐of‐function experiments including proliferation, migration/invasion, and radiosensitivity assays. Results: FKBP10 emerged as the only gene achieving statistical significance in both discovery (log2FC = 0.74, p = 0.0007) and validation (log2FC = 0.52, p = 0.032) cohorts among 48 radioresistance‐associated genes. Single‐cell profiling revealed that FKBP10 was predominantly expressed in cancer‐associated fibroblasts (CAFs, 51.5% of stromal cells), implicating CAF‐mediated stromal remodeling in resistance. FKBP10 knockdown significantly inhibited proliferation, colony formation (35%–40% reduction), migration (30%), and invasion (50%), while markedly enhancing radiosensitivity through increased DNA damage ( γ H2AX foci increased twofold, p < 0.01) and strand breaks (comet tail DNA: 22% → 43%, p < 0.01). Conclusions: This multiomics study establishes FKBP10 as a robust CAF‐derived biomarker and functional therapeutic target for radiotherapy resistance in CRC, providing a foundation for developing FKBP10‐targeted combination strategies for precision cancer treatment.

3 April 2023
Verified
Other
Open access
RWRui Wang
Rui Wang
HLHongwei Liu
Hongwei Liu
YSYing-Ying Shao
Ying-Ying Shao
KWKailong Wang
Kailong Wang
SYShuangshuang Yin
Shuangshuang Yin
HYHaiyang Yu
Haiyang Yu
The pharmacokinetic parameters of the main chemical constituents of Radian Sophorae flavescentis

3 April 2023
Verified
Other
Open access
RWRui Wang
Rui Wang
HLHongwei Liu
Hongwei Liu
YSYingying Shao
Yingying Shao
KWKailong Wang
Kailong Wang
SYShuangshuang Yin
Shuangshuang Yin
HYHaiyang Yu
Haiyang Yu
Main serum biochemical index of Sophoridine

3 April 2023
Verified
Other
Open access
RWRui Wang
Rui Wang
HLHongwei Liu
Hongwei Liu
YSYing-Ying Shao
Ying-Ying Shao
KWKailong Wang
Kailong Wang
SYShuangshuang Yin
Shuangshuang Yin
HYHaiyang Yu
Haiyang Yu
Main serum biochemical index of Sophoridine